drugset / Trial / NCT02397603

Peri-neural Dexmedetomidine as an Adjuvant to Bupivacaine Induced Paravertebral Block in Patients Undergonig Thoracotomy

NCT02397603

Phase 2 Completed 40 enrolled Cairo University
RandomizedParallel-groupTriple-blindTreatment

Summary

This study evaluates the effect of adding dexmedetomidine as an adjuvant to bupivacaine in patients undergoing thoracotomy when administered peri-neurally in thoracic paravertebral space.

Timeline

Start
2015-02
Primary completion
2015-11
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 50 ug Other
Comparator Bupivacaine Other / unclassified 20 ml Other

Indications

No indication recorded.